These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21353483)

  • 1. Serological evidence of exposure to Herpes Simplex Virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample.
    Yolken RH; Torrey EF; Lieberman JA; Yang S; Dickerson FB
    Schizophr Res; 2011 May; 128(1-3):61-5. PubMed ID: 21353483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Ruslanova I; Yolken RH
    Arch Gen Psychiatry; 2003 May; 60(5):466-72. PubMed ID: 12742867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.
    Dickerson F; Stallings C; Sullens A; Origoni A; Leister F; Krivogorsky B; Yolken R
    Brain Behav Immun; 2008 Oct; 22(7):1103-1107. PubMed ID: 18571372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Krivogorsky B; Yolken RH
    Biol Psychiatry; 2004 Mar; 55(6):588-93. PubMed ID: 15013827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
    Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
    Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to herpes simplex virus, type 1 and reduced cognitive function.
    Thomas P; Bhatia T; Gauba D; Wood J; Long C; Prasad K; Dickerson FB; Gur RE; Gur RC; Yolken RH; Nimgaonkar VL; Deshpande SN
    J Psychiatr Res; 2013 Nov; 47(11):1680-5. PubMed ID: 23920011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia.
    Schretlen DJ; Vannorsdall TD; Winicki JM; Mushtaq Y; Hikida T; Sawa A; Yolken RH; Dickerson FB; Cascella NG
    Schizophr Res; 2010 May; 118(1-3):224-31. PubMed ID: 20153952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Herpes simplex virus type 1 on cognitive impairments in young, healthy individuals - A historical prospective study.
    Fruchter E; Goldberg S; Fenchel D; Grotto I; Ginat K; Weiser M
    Schizophr Res; 2015 Oct; 168(1-2):292-6. PubMed ID: 26362735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.
    Shirts BH; Prasad KM; Pogue-Geile MF; Dickerson F; Yolken RH; Nimgaonkar VL
    Schizophr Res; 2008 Dec; 106(2-3):268-74. PubMed ID: 18801645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.
    Stroup S; Appelbaum P; Swartz M; Patel M; Davis S; Jeste D; Kim S; Keefe R; Manschreck T; McEvoy J; Lieberman J
    Schizophr Res; 2005 Dec; 80(1):1-8. PubMed ID: 16182516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH
    Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
    Hamdani N; Daban-Huard C; Godin O; Laouamri H; Jamain S; Attiba D; Delavest M; Lépine JP; Le Corvoisier P; Houenou J; Richard JR; Yolken RH; Krishnamoorthy R; Tamouza R; Leboyer M; Dickerson FB
    J Clin Psychiatry; 2017 Jan; 78(1):e18-e27. PubMed ID: 27929612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.
    Prasad KM; Eack SM; Keshavan MS; Yolken RH; Iyengar S; Nimgaonkar VL
    Schizophr Bull; 2013 Jul; 39(4):857-66. PubMed ID: 22446565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to infectious agents in individuals with recent onset schizophrenia.
    Leweke FM; Gerth CW; Koethe D; Klosterkötter J; Ruslanova I; Krivogorsky B; Torrey EF; Yolken RH
    Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):4-8. PubMed ID: 14991372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
    Breier A; Buchanan RW; D'Souza D; Nuechterlein K; Marder S; Dunn W; Preskorn S; Macaluso M; Wurfel B; Maguire G; Kakar R; Highum D; Hoffmeyer D; Coskinas E; Litman R; Vohs JL; Radnovich A; Francis MM; Metzler E; Visco A; Mehdiyoun N; Yang Z; Zhang Y; Yolken RH; Dickerson FB
    Schizophr Res; 2019 Apr; 206():291-299. PubMed ID: 30478008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis.
    Dickerson F; Schroeder JR; Nimgaonkar V; Gold J; Yolken R
    Psychiatry Res; 2020 Sep; 291():113157. PubMed ID: 32593064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent infection with neurotropic herpes viruses and cognitive impairment.
    Watson AM; Prasad KM; Klei L; Wood JA; Yolken RH; Gur RC; Bradford LD; Calkins ME; Richard J; Edwards N; Savage RM; Allen TB; Kwentus J; McEvoy JP; Santos AB; Wiener HW; Go RC; Perry RT; Nasrallah HA; Gur RE; Devlin B; Nimgaonkar VL
    Psychol Med; 2013 May; 43(5):1023-31. PubMed ID: 22975221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.